Analyst Rating
based on 19 analysts
63.16%
Buy
15.79%
Hold
21.05%
Sell
Based on 19 analysts offering long term price targets for Max Healthcare Institute Ltd. An average target of ₹922
Source: S&P Global Market Intelligence
Max Healthcare Institute Ltd Share analysis
Max Healthcare Institute Ltd price forecast by 19 analysts
Downside of
High
₹1060
Target
₹922.00
Low
₹560
Max Healthcare Institute Ltd target price ₹922, a slight downside of -4.43% compared to current price of ₹962.95. According to 19 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Max Healthcare Institute Ltd revenue growth forecast
Expected growth rate Q1, FY2026:76.77%
Forecast
Actual
Including amortisation and stock based compensations
Max Healthcare Institute Ltd EPS growth forecast
EPS estimate Q1, FY2026:80.88%
Forecast
Actual
Source: S&P Global Market Intelligence
Performance
Day's Low
Day's High
₹941.3₹975.0552 Week's Low
52 Week's High
₹531.05₹979.9
| Returns % | |
| 1 Month Return | + 10.31 % |
| 3 Month Return | + 6.83 % |
| 1 Year Return | + 67.95 % |
| Market Stats | |
| Previous Close | ₹964.70 |
| Open | ₹964.70 |
| Volume | 11.94L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹93,781.58Cr |
Key Statistics
| P/E Ratio | 88.91 |
| PEG Ratio | -73.48 |
| Market Cap | ₹93,781.58 Cr |
| P/B Ratio | 10.38 |
| EPS | 10.88 |
| Dividend Yield | 0.18 |
| Sector | Healthcare |
| ROE | 9.34 |
Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹93,781.58 Cr | 152.65% | 0.53 | ₹1,057 Cr | ₹5,704 Cr | |
| BUY | ₹45,588.15 Cr | 76.81% | 0.54 | ₹645 Cr | ₹7,175 Cr | |
| BUY | ₹1,00,765.01 Cr | 77.75% | 0.65 | ₹917 Cr | ₹19,059 Cr | |
| BUY | ₹26,236.86 Cr | 88.23% | 0.69 | ₹789 Cr | ₹5,018 Cr | |
| BUY | ₹22,489.81 Cr | 36.38% | 0.58 | ₹336 Cr | ₹2,498 Cr |
Mutual Fund Holdings
Company Information
Max Healthcare Institute Ltd is one of the top healthcare providers in India, offering a wide range of products and services. Its top products include diagnostic services, medical imaging, laboratory testing, and surgical services. The company also offers a range of popular brands such as Max Super Specialty Hospital, Max Multi Specialty Centre, Max Smart Super Specialty Hospital, and Max Healthcare.
Share Price: ₹962.95 per share as on 18 Sep, 2024 04:01 PM
Market Capitalisation: ₹93,781.58Cr as of today
Revenue: ₹1,542.95Cr as on June 2024 (Q2 24)
Net Profit: ₹236.27Cr as on June 2024 (Q2 24)
Listing date: 20 Aug, 2020
Chairperson Name: Abhay Soi
| Organisation | Max Healthcare Institute Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Max Healthcare Institute Ltd
Max Healthcare Acquires Controlling Stake in Jaypee Healthcare - 17 Sep, 2024
Max Healthcare Institute announced the acquisition of a controlling stake in Jaypee Healthcare for Rs 1,660 crore, adding 700 beds and enhancing its capabilities. However, increased operating expenses and competition from Medanta's new facility may impact future performance.
Max Healthcare Acquires Majority Stake in Jaypee Healthcare - 16 Sep, 2024
Max Healthcare Institute has entered a strategic collaboration to acquire a 64% stake in Jaypee Healthcare for Rs 1,660 crore, enhancing its presence in the NCR. The deal includes plans to settle JHL's debts and options for future stake acquisition.
Max Healthcare Acquires Stake in Jaypee Healthcare - 14 Sep, 2024
Max Healthcare is set to acquire a 64% stake in Jaypee Healthcare for ₹1,660 crore, strengthening its foothold in the NCR region. The deal includes debt arrangements for Jaypee's creditors and is expected to close within 30 days.
Max Healthcare Acquires Controlling Stake in Jaypee Healthcare - 13 Sep, 2024
Max Healthcare Institute has entered a strategic collaboration to acquire a 64% stake in Jaypee Healthcare for Rs 1,660 crore, enhancing its presence in the NCR region. The acquisition includes the flagship 500-bed Jaypee Hospital in Noida, with plans for future expansion.
Max Healthcare Subsidiary Approves Voluntary Liquidation - 11 Sep, 2024
The Board of Directors of ET Planners Private Limited, a wholly-owned subsidiary of Max Healthcare, has approved voluntary liquidation to consolidate its business with Alps Hospital Limited.
Max Healthcare Expected to Grow Significantly - 04 Sep, 2024
Max Healthcare is projected to achieve a 2.5x stock growth in five years, with a 20% EBITDA CAGR from FY24 to FY30. However, risks like construction delays and overpriced acquisitions are noted.
Max Healthcare Reports Strong Revenue Growth - 25 Aug, 2024
Max Healthcare Institute Ltd reported a 20% year-on-year increase in revenue to Rs 1,543 crore for the June quarter, driven by growth in oncology, orthopaedics, and renal sciences, along with more robotic procedures.
Max Healthcare Declares Final Dividend Announcement - 23 Aug, 2024
Max Healthcare Institute Ltd has declared a final dividend of Rs 1.50 per share, with the ex-dividend date set for August 23, 2024.
Insights on Max Healthcare Institute Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, MAXHEALTH stock has moved up by 10.0%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 1.38K Cr → 1.57K Cr (in ₹), with an average increase of 6.4% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, MAXHEALTH has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services
NO EFFECTAgainst Peers
In the last 1 year, Fortis Healthcare Ltd has given 85.6% return, outperforming this stock by 17.6%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 12.33% to 12.19% in Jun 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 23.75% to 23.74% in Jun 2024 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 57.33% to 56.98% in Jun 2024 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 289.34 Cr → 236.27 Cr (in ₹), with an average decrease of 9.6% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 3.96% to 3.91% in Jun 2024 quarter
Company Financials
Index Inclusions
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 23.74% | ||
| Foreign Institutions | 56.98% | ||
| Mutual Funds | 12.19% | ||
| Retail Investors | 3.91% | ||
| Others | 3.18% | 20.89 |
Key Indicators
Max Healthcare Institute Ltd Valuation
Max Healthcare Institute Ltd in the last 5 years
Lowest (-108.44x)
June 23, 2021
Today (88.91x)
September 17, 2024
Industry (96.97x)
September 17, 2024
Highest (114.93x)
September 16, 2021
Earnings and Dividends
Max Healthcare Institute Ltd Earnings Results
Max Healthcare Institute Ltd’s net profit fell -1.59% since last year same period to ₹236.27Cr in the Q1 2024-2025. On a quarterly growth basis, Max Healthcare Institute Ltd has generated -6.07% fall in its net profits since last 3-months.
Read More about Earnings ResultsMax Healthcare Institute Ltd Dividends May,2024
In the quarter ending March 2024, Max Healthcare Institute Ltd has declared dividend of ₹1.50 - translating a dividend yield of 0.16%.
Read More about Dividends
Technicals Summary
Bearish
Neutral
Bullish
Max Healthcare Institute Ltd is currently in a Bullish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Max Healthcare Institute Ltd shares.
Max Healthcare Institute Ltd (MAXHEALTH) share price today is ₹962.95
Max Healthcare Institute Ltd is listed on NSE
Max Healthcare Institute Ltd is listed on BSE
- Today’s highest price of Max Healthcare Institute Ltd is ₹975.05.
- Today’s lowest price of Max Healthcare Institute Ltd is ₹941.3.
PE Ratio of Max Healthcare Institute Ltd is 88.91
PE ratio = Max Healthcare Institute Ltd Market price per share / Max Healthcare Institute Ltd Earnings per share
Today’s traded volume of Max Healthcare Institute Ltd(MAXHEALTH) is 11.94L.
Today’s market capitalisation of Max Healthcare Institute Ltd(MAXHEALTH) is ₹93781.58Cr.
| Max Healthcare Institute Ltd(MAXHEALTH | Price |
|---|---|
52 Week High | ₹979.9 |
52 Week Low | ₹531.05 |
Max Healthcare Institute Ltd(MAXHEALTH) share price is ₹962.95. It is down -1.73% from its 52 Week High price of ₹979.9
Max Healthcare Institute Ltd(MAXHEALTH) share price is ₹962.95. It is up 81.33% from its 52 Week Low price of ₹531.05
| Max Healthcare Institute Ltd(MAXHEALTH | Returns |
|---|---|
1 Day Returns | -1.75% |
1 Month Returns | 10.31% |
3 Month Returns | 6.83% |
1 Year Returns | 67.95% |